InsiderGauge
Checking updates…
Dashboard

Matsuda Masaruinsider trades

In SEC Form 4 filings, Matsuda Masaru is listed as See Remarks of Arcutis Biotherapeutics, Inc. (ARQT). In the last 90 days, Matsuda Masaru sold $341.8K of Arcutis Biotherapeutics, Inc. (ARQT) on the open market and bought none. All 2 sales were reported under a 10b5-1 trading plan.

Companies and roles

CompanyRoleTransactionsLast filed
ARQTArcutis Biotherapeutics, Inc.See Remarks2Sep 18

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-10

CompanyTradedFiledTypeSharesPriceValueOwned after10b5-1 planFiling
ARQTArcutis Biotherapeutics, Inc.Sep 16Sep 18S3,674$25.00Sale −$91,853112,508YesForm 4
ARQTArcutis Biotherapeutics, Inc.Sep 8Sep 10S9,989$25.03Sale −$249,986116,182YesForm 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.